Skip to main content
. 2022 Mar 14;21(5):e12803. doi: 10.1111/gbb.12803

TABLE 1.

Variables for consideration, key to behavioral outcomes

Guidance Addresses Recommend References
Sample size blinding randomization Power false reporting N = 15–20 per genotype/treatment/sex 50, 51, 52
Age and sex Age‐dependent effects One sex cannot be tested; genders cannot be combined with powered Ns and statistics showing no difference; Animals of wildly different ages cannot be compared 53, 54, 55
Sex‐specific effects
Breeding schema Developmental environment WT × WT and KO × KO is unacceptable; a KO's maternal behavior is likely different than WT; thus, het by het breeding recommended 51, 52, 55, 56, 57, 58, 59
Housing conditions Developmental environment Housed within genotype/treatment or mixed genotype/treatment; house isolated or grouped 51, 52, 58, 60
Background strain Background genetics Consistent reporting/congenic when possible 55, 61, 62
Order of testing Test‐re test influencing on behavior Non stressful to stressful 63, 64, 65
Littermates or litter effects Developmental environment consistency Reporting and accounting for appropriate control subjects accounting for maternal care; litter size 66, 67, 68, 69
Task validation Tests must be validated to measure what you are assessing. Examples include a benzodiazepine will change behavior in an anxiety test and/or a sedative lower motor activity 57
Reproducibility Chance findings/type 1 error For rigorous, reliable behavioral outcome measures 59, 70